Evidence map›Paper›PMID 34372507›Full record

ArticleViruses2021

Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection.

Ivonne Melano, Li-Lan Kuo, Yan-Chung Lo, Po-Wei Sung, Ni Tien, Wen-Chi Su

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Romanian Wild-GrowingPlants (Basel, Switzerland) · 2024
    Article
  8. An Innovative Approach to a Potential NeuroprotectiveInternational journal of molecular sciences · 2024
    Article
  9. Wnt3a Facilitates SARS-CoV-2 Pseudovirus Entry into Cells.International journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms".International journal of molecular sciences · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ivonne MelanoGraduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-6057-9013
Li-Lan KuoResearch Center for Emerging Viruses, China Medical University Hospital, Taichung 40402, Taiwan.
Yan-Chung LoSinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan.
Po-Wei SungSchool of Medicine, China Medical University, Taichung 40402, Taiwan.
Ni TienDepartment of Laboratory Medicine, China Medical University Hospital, Taichung 40402, Taiwan.
Wen-Chi SuGraduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0001-9828-6542
China Medical University · TW

Funding

China Medical University, Taiwan CMU109-MF-23Ministry of Science and Technology, Taiwan MOST 109-2320-B-039-050
6 · The paper itself

Abstract

Amino acids have been implicated with virus infection and replication. Here, we demonstrate the effects of two basic amino acids, arginine and lysine, and their ester derivatives on infection of two enveloped viruses, SARS-CoV-2, and influenza A virus. We found that lysine and its ester derivative can efficiently block infection of both viruses in vitro. Furthermore, the arginine ester derivative caused a significant boost in virus infection. Studies on their mechanism of action revealed that the compounds potentially disturb virus uncoating rather than virus attachment and endosomal acidification. Our findings suggest that lysine supplementation and the reduction of arginine-rich food intake can be considered as prophylactic and therapeutic regimens against these viruses while also providing a paradigm for the development of broad-spectrum antivirals.

Indexed as

COVID-19 Drug TreatmentA549 CellsAmino Acids, BasicAngiotensin-Converting Enzyme 2Antiviral AgentsCOVID-19HEK293 CellsHumansInfluenza A virusInfluenza, HumanSARS-CoV-2Spike Glycoprotein, CoronavirusVirus AttachmentVirus ReplicationACE2 protein, humanAmino Acids, BasicAngiotensin-Converting Enzyme 2Antiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2antiviral therapyarginineCOVID-19disease preventioninfluenza A viruslysineSARS-CoV-2

Identifiers

PMID34372507
PMCPMC8310019
OpenAlexW3182965283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.